News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,927 Results
Type
Article (40366)
Company Profile (298)
Press Release (662263)
Section
Business (206957)
Career Advice (2070)
Deals (35865)
Drug Delivery (98)
Drug Development (82299)
Employer Resources (173)
FDA (16212)
Job Trends (15145)
News (349827)
Policy (32806)
Tag
Academia (2557)
Alliances (50128)
Alzheimer's disease (1341)
Approvals (16196)
Artificial intelligence (212)
Bankruptcy (360)
Best Places to Work (11757)
Biotechnology (213)
Breast cancer (231)
Cancer (1781)
Cardiovascular disease (136)
Career advice (1721)
CAR-T (129)
Cell therapy (374)
Clinical research (66387)
Collaboration (700)
Compensation (385)
COVID-19 (2591)
C-suite (175)
Data (1698)
Diabetes (220)
Diagnostics (6318)
Earnings (86671)
Employer resources (149)
Events (113510)
Executive appointments (593)
FDA (17156)
Funding (620)
Gene therapy (257)
GLP-1 (684)
Government (4404)
Healthcare (18867)
Infectious disease (2708)
Inflammatory bowel disease (126)
Interviews (328)
IPO (16703)
Job creations (3834)
Job search strategy (1468)
Layoffs (454)
Legal (7940)
Lung cancer (258)
Manufacturing (246)
Medical device (13292)
Medtech (13297)
Mergers & acquisitions (19554)
Metabolic disorders (581)
Neuroscience (1768)
NextGen: Class of 2025 (6568)
Non-profit (4495)
Northern California (2183)
Obesity (318)
Opinion (213)
Patents (173)
People (57744)
Phase I (20711)
Phase II (29304)
Phase III (21701)
Pipeline (784)
Postmarket research (2572)
Preclinical (8734)
Radiopharmaceuticals (252)
Rare diseases (331)
Real estate (6021)
Regulatory (22230)
Research institute (2337)
Resumes & cover letters (354)
Southern California (1873)
Startups (3651)
United States (19331)
Vaccines (633)
Weight loss (222)
Date
Today (62)
Last 7 days (836)
Last 30 days (2674)
Last 365 days (34753)
2025 (5362)
2024 (35730)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35385)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (740)
Arizona (213)
Asia (38840)
Australia (6278)
California (4983)
Canada (1752)
China (424)
Colorado (227)
Connecticut (237)
Europe (83739)
Florida (740)
Georgia (171)
Illinois (465)
Indiana (272)
Maryland (771)
Massachusetts (3817)
Michigan (200)
Minnesota (346)
New Jersey (1415)
New York (1424)
North Carolina (906)
Northern California (2183)
Ohio (175)
Pennsylvania (1133)
South America (1118)
Southern California (1873)
Texas (733)
Utah (154)
Washington State (483)
702,927 Results for "enteris biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
February 20, 2025
·
5 min read
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
5 min read
·
Heather McKenzie
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
February 6, 2025
·
1 min read
·
Angela Gabriel
Interviews
The 4 Biggest Job Interview Mistakes Biopharma Professionals Make
As they navigate a competitive job market, biopharma professionals are making four key interview mistakes, according to two talent acquisition experts. They discuss those errors and offer tips for how to get those critical conversations right.
February 27, 2025
·
6 min read
·
Angela Gabriel
Layoffs
Layoffs Continued Across Biopharma in 2024
While layoffs slowed in the second half of 2024, biopharmas including Bayer, Bristol Myers Squibb and Johnson & Johnson cut hundreds or even thousands of employees over the course of the year.
December 31, 2024
·
130 min read
·
BioSpace Editorial Staff
Government
WHO Withdrawal, CGT Access, IRA: Trump’s Initial Policies Raise Questions for Biopharma
At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, President Trump issued multiple executive orders that concern the industry.
January 22, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
February 26, 2025
·
6 min read
Collaboration
The Top 7 Biopharma Licensing Deals of 2024
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their pipelines with novel and potentially more effective therapies.
February 5, 2025
·
8 min read
·
Tristan Manalac
1 of 70,293
Next
